Undetectable dystrophin can still result in a relatively benign phenotype of dystrophinopathy

被引:16
作者
Hattori, N
Kaido, M
Nishigaki, T
Inui, K
Fujimura, H
Nishimura, T
Naka, T
Hazama, T
机构
[1] Osaka Univ, Grad Sch Med, Dept Neurol D4, Suita, Osaka 5650871, Japan
[2] Osaka Prefectural Gen Hosp, Dept Neurol, Sumiyoshi Ku, Osaka 5588558, Japan
[3] Osaka Univ, Grad Sch Med, Dept Pediat D5, Suita, Osaka 5650871, Japan
关键词
Becker muscular dystrophy; dystrophin; beta-dystroglycan; utrophin;
D O I
10.1016/S0960-8966(99)00005-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We present here a 28-year-old male patient with Becker muscular dystrophy whose skeletal muscle showed an absence of dystrophin. He has had progressive and predominantly proximal muscular wasting since 5 years of age, but was able to walk until 26 years of age. He showed hypertrophic calves, cardiomyopathy, and an elevated serum creatine kinase level (934 U/l), A skeletal muscle biopsy revealed advanced chronic myopathic changes. Immunohistochemical examination using anti-dystrophin antibodies against C-terminus showed deficiency of the protein. Rod domain and N-terminus were also absent in almost all muscle fibers, but only in a small part of the sample, they were faintly stained. beta-Dystroglycan and utrophin were present only in a small number of muscle fibers. DNA and RT-PCR analysis showed a frame-shift deletion of exons 3-7 in the dystrophin gene. In such an exceptional case as this one, it is important to investigate the factors which determine the severity of dystrophinopathy. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 26 条
[1]   IMMUNOSTAINING OF SKELETAL AND CARDIAC-MUSCLE SURFACE-MEMBRANE WITH ANTIBODY AGAINST DUCHENNE MUSCULAR-DYSTROPHY PEPTIDE [J].
ARAHATA, K ;
ISHIURA, S ;
ISHIGURO, T ;
TSUKAHARA, T ;
SUHARA, Y ;
EGUCHI, C ;
ISHIHARA, T ;
NONAKA, I ;
OZAWA, E ;
SUGITA, H .
NATURE, 1988, 333 (6176) :861-863
[2]   A NOVEL PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY GENE WHICH GREATLY DIFFERS FROM THE KNOWN ISOFORMS IN ITS STRUCTURE AND TISSUE DISTRIBUTION [J].
BAR, S ;
BARNEA, E ;
LEVY, Z ;
NEUMAN, S ;
YAFFE, D ;
NUDEL, U .
BIOCHEMICAL JOURNAL, 1990, 272 (02) :557-560
[3]  
BEGGS AH, 1990, HUM GENET, V86, P45
[4]  
BUSHBY KMD, 1994, BAILLIERE CLIN NEUR, V3, P407
[5]  
Chamberlain JS, 1990, PCR PROTOCOLS GUIDE, P272
[6]   Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy [J].
Deconinck, AE ;
Rafael, JA ;
Skinner, JA ;
Brown, SC ;
Potter, AC ;
Metzinger, L ;
Watt, DJ ;
Dickson, JG ;
Tinsley, JM ;
Davies, KE .
CELL, 1997, 90 (04) :717-727
[7]   A NOVEL DYSTROPHIN ISOFORM IS REQUIRED FOR NORMAL RETINAL ELECTROPHYSIOLOGY [J].
DSOUZA, VN ;
MAN, NT ;
MORRIS, GE ;
KARGES, W ;
PILLERS, DAM ;
RAY, PN .
HUMAN MOLECULAR GENETICS, 1995, 4 (05) :837-842
[8]  
EMERY AEH, 1976, CLIN GENET, V10, P189
[9]  
GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562
[10]   CHARACTERIZATION OF DYSTROPHIN IN MUSCLE-BIOPSY SPECIMENS FROM PATIENTS WITH DUCHENNES OR BECKERS MUSCULAR-DYSTROPHY [J].
HOFFMAN, EP ;
FISCHBECK, KH ;
BROWN, RH ;
JOHNSON, M ;
MEDORI, R ;
LOIKE, JD ;
HARRIS, JB ;
WATERSTON, R ;
BROOKE, M ;
SPECHT, L ;
KUPSKY, W ;
CHAMBERLAIN, J ;
CASKEY, CT ;
SHAPIRO, F ;
KUNKEL, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (21) :1363-1368